Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus
- PMID: 38836231
- PMCID: PMC11148232
- DOI: 10.3389/fendo.2024.1365738
Epigenetics of hypertension as a risk factor for the development of coronary artery disease in type 2 diabetes mellitus
Abstract
Hypertension, a multifaceted cardiovascular disorder influenced by genetic, epigenetic, and environmental factors, poses a significant risk for the development of coronary artery disease (CAD) in individuals with type 2 diabetes mellitus (T2DM). Epigenetic alterations, particularly in histone modifications, DNA methylation, and microRNAs, play a pivotal role in unraveling the complex molecular underpinnings of blood pressure regulation. This review emphasizes the crucial interplay between epigenetic attributes and hypertension, shedding light on the prominence of DNA methylation, both globally and at the gene-specific level, in essential hypertension. Additionally, histone modifications, including acetylation and methylation, emerge as essential epigenetic markers linked to hypertension. Furthermore, microRNAs exert regulatory influence on blood pressure homeostasis, targeting key genes within the aldosterone and renin-angiotensin pathways. Understanding the intricate crosstalk between genetics and epigenetics in hypertension is particularly pertinent in the context of its interaction with T2DM, where hypertension serves as a notable risk factor for the development of CAD. These findings not only contribute to the comprehensive elucidation of essential hypertension but also offer promising avenues for innovative strategies in the prevention and treatment of cardiovascular complications, especially in the context of T2DM.
Keywords: DNA methylation; coronary artery disease; epigenetics; genetic variation; histone; hypertension; modification; type 2 diabetes mellitus.
Copyright © 2024 Karabaeva, Vochshenkova, Mussin, Albayev, Kaliyev and Tamadon.
Conflict of interest statement
The author AT was employed by the company PerciaVista R&D Co. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


References
-
- Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. (2012) 380:2224–60. doi: 10.1016/S0140-6736(12)61766-8 - DOI - PMC - PubMed
-
- Parati G, Bilo G, Kollias A, Pengo M, Ochoa JE, Castiglioni P, et al. . Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper *. J Hypertens. (2023) 41:527–44. doi: 10.1097/HJH.0000000000003363 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous